Lv6
2350 积分 2021-08-10 加入
LBA84 Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D-mutant pancreatic ductal adenocarcinoma (PDAC)
19天前
已关闭
2215O HRS-4642 combined with gemcitabine and nab-paclitaxel in KRAS-G12D mutant advanced pancreatic cancer: A phase Ib/II study
19天前
已关闭
Trends in gene therapy delivery technologies
27天前
已完结
Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome
3个月前
已完结
Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation
11个月前
已完结
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study
11个月前
已完结
Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directions
1年前
已完结
Targeting cancer with small molecule pan-KRAS degraders
1年前
已完结
Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis
1年前
已完结
皖公网安备34019202002308
